|
1
|
Gu D, Reynolds K, Wu X, Chen J, Duan X,
Muntner P, Huang G, Reynolds RF, Su S, Whelton PK, et al:
Prevalence, awareness, treatment, and control of hypertension in
China. Hypertension. 40:920–927. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brandão AP, Brandão AA, Araújo EM and
Oliveira RC: Familial aggregation of arterial blood pressure and
possible genetic influence. Hypertension. 19 Suppl 2:II214–II217.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wallace DC: Mitochondrial defects in
cardiomyopathy and neuromuscular disease. Am Heart J. 139
Suppl:S70–S85. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hirano M, Davidson M and DiMauro S:
Mitochondria and the heart. Curr Opin Cardiol. 16:201–210. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu Y, Li R, Li Z, Wang XJ, Yang L, Wang S
and Guan MX: Mitochondrial transfer RNAMet 4435A>G mutation is
associated with maternally inherited hypertension in a Chinese
pedigree. Hypertension. 53:1083–1090. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li Z, Liu Y, Yang L, Wang S and Guan MX:
Maternally inherited hypertension is associated with the
mitochondrial tRNA(Ile) A4295G mutation in a Chinese family.
Biochem Biophys Res Commun. 367:906–911. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang S, Li R, Fettermann A, Li Z, Qian Y,
Liu Y, Wang X, Zhou A, Mo JQ, Yang L, et al: Maternally inherited
essential hypertension is associated with the novel 4263A>G
mutation in the mitochondrial tRNAIle gene in a large Han Chinese
family. Circ Res. 108:862–870. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen H, Zheng J, Xue L, Meng Y, Wang Y,
Zheng B, Fang F, Shi S, Qiu Q, Jiang P, et al: The 12S rRNA A1555G
mutation in the mitochondrial haplogroup D5a is responsible for
maternally inherited hypertension and hearing loss in two Chinese
pedigrees. Eur J Hum Genet. 20:607–612. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu Y, Li Z, Yang L, Wang S and Guan MX:
The mitochondrial ND1 T3308C mutation in a Chinese family with the
secondary hypertension. Biochem Biophys Res Commun. 368:18–22.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Palecek T, Tesarova M, Kuchynka P, Dytrych
V, Elleder M, Hulkova H, Hansikova H, Honzik T, Zeman J and Linhart
A: Hypertrophic cardiomyopathy due to the mitochondrial DNA
mutation m.3303C>T diagnosed in an adult male. Int Heart J.
53:383–387. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Teng L, Zheng J, Leng J and Ding Y:
Clinical and molecular characterization of a Han Chinese family
with high penetrance of essential hypertension. Mitochondrial DNA.
23:461–465. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Whitworth JA: World Health Organization,
International Society of Hypertension Writing Group: 2003 world
health organization (WHO)/international society of hypertension
(ISH) statement on management of hypertension. J Hypertens.
21:1983–1992. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Arima H, Tanizaki Y, Kiyohara Y,
Tsuchihashi T, Kato I, Kubo M, Tanaka K, Ohkubo K, Nakamura H, Abe
I, et al: Validity of the JNC VI recommendations for the management
of hypertension in a general population of Japanese elderly: The
Hisayama study. Arch Intern Med. 163:361–366. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rieder MJ, Taylor SL, Tobe VO and
Nickerson DA: Automating the identification of DNA variations using
quality-based fluorescence re-sequencing: Analysis of the human
mitochondrial genome. Nucleic Acids Res. 26:967–973. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yarham JW, Al-Dosary M, Blakely EL, Alston
CL, Taylor RW, Elson JL and McFarland R: A comparative analysis
approach to determining the pathogenicity of mitochondrial tRNA
mutations. Hum Mutat. 32:1319–1325. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ding Y, Xia B, Yu J, Leng J and Huang J:
Mitochondrial DNA mutations and essential hypertension (Review).
Int J Mol Med. 32:768–774. 2013.PubMed/NCBI
|
|
17
|
Bibb MJ, Van Etten RA, Wright CT, Walberg
MW and Clayton DA: Sequence and gene organization of mouse
mitochondrial DNA. Cell. 26:167–180. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gadaleta G, Pepe G, De Candia G,
Quagliariello C, Sbisà E and Saccone C: The complete nucleotide
sequence of the Rattus norvegicus mitochondrial genome: Cryptic
signals revealed by comparative analysis between vertebrates. J Mol
Evol. 28:497–516. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Roe BA, Ma DP, Wilson RK and Wong JF: The
complete nucleotide sequence of the Xenopus laevis mitochondrial
genome. J Biol Chem. 260:9759–9774. 1985.PubMed/NCBI
|
|
20
|
Ojala D, Montoya J and Attardi G: tRNA
punctuation model of RNA processing in human mitochondria. Nature.
290:470–474. 1981. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Andrews RM, Kubacka I, Chinnery PF,
Lightowlers RN, Turnbull DM and Howell N: Reanalysis and revision
of the Cambridge reference sequence for human mitochondrial DNA.
Nat Genet. 23:1471999. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhu HY, Wang SW, Liu L, Li YH, Chen R,
Wang L and Holliman CJ: A mitochondrial mutation A4401G is involved
in the pathogenesis of left ventricular hypertrophy in Chinese
hypertensives. Eur J Hum Genet. 17:172–178. 2009. View Article : Google Scholar : PubMed/NCBI
|
